Urotensin II Protects Cardiomyocytes from Apoptosis Induced by Oxidative Stress through the CSE/H2S Pathway

Hui Gong, Zhidan Chen, Xiaoyi Zhang, Yang Li, Jie Zhang, Ying Chen, Ying-Jiong Ding, Guoping Zhang, Chunjie Yang, Yi‐Chun Zhu, Yunzeng ZouInternational Journal of Molecular Sciences 2015 · DOI

TL;DR

This study reveals that Urotensin II (UII) protects heart cells (cardiomyocytes) from death caused by oxidative stress. It does this by activating a signaling pathway involving ERK, which then boosts the production of hydrogen sulfide (H2S) through the enzyme CSE. This UII-CSE/H2S-ERK axis appears to be a key mechanism for UII's protective effects in the heart, particularly relevant in conditions like acute myocardial infarction.

What Problem Does This Paper Address?

Acute myocardial infarction (heart attack) is a major cause of mortality and morbidity. Oxidative stress, a state where the body's antioxidant defenses are overwhelmed by reactive oxygen species, plays a critical role in the death of cardiomyocytes during a heart attack. While elevated levels of Urotensin II (UII) have been observed in patients with acute myocardial infarction and are associated with better outcomes, the precise molecular mechanisms behind its potential cardioprotective role remain unclear. This paper aims to elucidate how UII protects cardiomyocytes from oxidative stress-induced apoptosis and to identify the key molecular players involved.

Methods

The researchers employed a multi-pronged approach using cultured neonatal rat cardiomyocytes:

  • Oxidative Stress Induction: Hydrogen peroxide (H2O2) was used to mimic oxidative stress and induce apoptosis in cardiomyocytes.
  • UII Treatment: Cardiomyocytes were pre-treated with UII before exposure to H2O2 to assess its protective effects.
  • Apoptosis Assessment: Terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end labeling (TUNEL) assay was used to quantify apoptotic cells. Western blotting was employed to measure the levels of pro-apoptotic (Bax) and anti-apoptotic (Bcl-2) proteins.
  • Molecular Pathway Investigation:
    • siRNA Knockdown: Small interfering RNA (siRNA) targeting the Urotensin II receptor (UT) and cystathionine-γ-lyase (CSE) were used to block the function of these molecules and assess their role.
  • Enzyme Activity Measurement: Hydrogen sulfide (H2S) production in the cell culture supernatant was measured.
  • Signaling Pathway Analysis: Western blotting was used to detect the phosphorylation status of Extracellular signal-regulated kinase (ERK), a key signaling molecule. An ERK inhibitor (U0126) was also used.
  • Gene Expression Analysis: Reverse transcription PCR (RT-PCR) was performed to examine the mRNA levels of CSE and its counterpart CBS.

Datasets

Not discussed in the paper. The study primarily relies on experimental data generated from cultured cells and analyses of tissue samples from a mouse model of myocardial infarction.

Key Insights and Ideas

  • UII as a Direct Cardiomyocyte Protector: The study provides direct evidence that UII can protect cardiomyocytes from H2O2-induced apoptosis, not just indirectly through systemic effects.
  • The UT Receptor is Crucial: Blocking the UII receptor (UT) with siRNA significantly diminished UII's anti-apoptotic effects, highlighting the receptor's essential role in mediating UII's protective actions.
  • H2S is a Key Mediator: UII significantly increases H2S production in cardiomyocytes under oxidative stress. This suggests H2S is a critical downstream effector of UII's protective signaling.
  • CSE is the Primary H2S Source in Cardiomyocytes: The study confirmed that CSE, not CBS, is the predominant enzyme responsible for H2S production in cardiomyocytes, and UII upregulates CSE.
  • ERK Signaling is Central: UII rapidly activates ERK phosphorylation, and this activation is necessary for both the upregulation of CSE and the anti-apoptotic effects of UII.
  • A Reciprocal Loop: The findings suggest a potential reciprocal relationship where UII-induced ERK activation leads to increased CSE and H2S, which in turn may further influence ERK activity, contributing to sustained cardioprotection.

Key Results

  • UII pretreatment significantly reduced the number of apoptotic cardiomyocytes induced by H2O2.
  • UII treatment reversed the H2O2-induced increase in the pro-apoptotic protein Bax and decrease in the anti-apoptotic protein Bcl-2.
  • Knockdown of the UII receptor (UT) partially abolished UII's anti-apoptotic effects.
  • UII treatment significantly increased H2S production in a time-dependent manner.
  • UII treatment significantly upregulated the level of CSE protein in cardiomyocytes.
  • UII rapidly promoted the phosphorylation of ERK in cardiomyocytes.
  • Inhibition of CSE (using si-CSE) or ERK (using U0126) partly reversed UII's anti-apoptotic effects and its impact on Bax/Bcl-2 levels.
  • Inhibition of CSE also significantly inhibited UII-induced ERK activation.

Limitations and Future Work

  • In Vitro vs. In Vivo: While the study uses cultured cardiomyocytes, the findings are extrapolated to the in vivo context of myocardial infarction. Further studies in animal models are needed to fully confirm these mechanisms in a complex physiological setting.
  • Specific ERK Activation Mechanisms: The paper speculates on several mechanisms by which UII might activate ERK (e.g., G-protein dependent signaling, EGFR transactivation, β-arrestin involvement). Further research is needed to pinpoint the exact pathways involved.
  • Other Pathways: The authors acknowledge that other pathways might also be involved in UII's protective effects and suggest further investigation.
  • Clinical Translation: While the study suggests that increased plasma UII may be protective in acute myocardial infarction, direct clinical validation of this specific pathway in patients is a future direction.
  • H2S and ERK Reciprocity: The potential reciprocal regulation between ERK and CSE/H2S needs more detailed exploration to fully understand the feedback loops involved.

Summary updated

Abstract

Plasma urotensin II (UII) has been observed to be raised in patients with acute myocardial infarction; suggesting a possible cardiac protective role for this peptide. However, the molecular mechanism is unclear. Here, we treated cultured cardiomyocytes with H2O2 to induce oxidative stress; observed the effect of UII on H2O2-induced apoptosis and explored potential mechanisms. UII pretreatment significantly reduced the number of apoptotic cardiomyocytes induced by H2O2; and it partly abolished the increase of pro-apoptotic protein Bax and the decrease of anti-apoptotic protein Bcl-2 in cardiomyocytes induced by H2O2. SiRNA targeted to the urotensin II receptor (UT) greatly inhibited these effects. Further analysis revealed that UII increased the production of hydrogen sulfide (H2S) and the level of cystathionine-γ-lyase (CSE) by activating the ERK signaling in H2O2-treated-cardiomyocytes. Si-CSE or ERK inhibitor not only greatly inhibited the increase in CSE level or the phosphorylation of ERK induced by UII but also reversed anti-apoptosis of UII in H2O2-treated-cadiomyocytes. In conclusion, UII rapidly promoted the phosphorylation of ERK and upregulated CSE level and H2S production, which in turn activated ERK signaling to protect cardiomyocytes from apoptosis under oxidative stress. These results suggest that increased plasma UII level may protect cardiomyocytes at the early-phase of acute myocardial infarction in patients.
BibTeX
@article{gong2015urotensin,
  author = {Hui Gong and Zhidan Chen and Xiaoyi Zhang and Yang Li and Jie Zhang and Ying Chen and Ying-Jiong Ding and Guoping Zhang and Chunjie Yang and Yi‐Chun Zhu and Yunzeng Zou},
  title = {{Urotensin II Protects Cardiomyocytes from Apoptosis Induced by Oxidative Stress through the CSE/H2S Pathway}},
  journal = {International Journal of Molecular Sciences},
  year = {2015},
  doi = {10.3390/ijms160612482},
}
Figure